Evan Tzanis
Directeur des opérations chez Neuraptive Therapeutics, Inc.
Profil
Evan Tzanis is currently the COO and Executive VP of Research & Development at Neuraptive Therapeutics, Inc. He previously worked as the Head of Clinical Operations & Biometrics at Endo Pharmaceuticals, Inc. from 2011 to 2014.
He also served as the Vice President of Clinical Development at Paratek Pharmaceuticals, Inc. from 2014 to 2017.
Postes actifs de Evan Tzanis
| Sociétés | Poste | Début |
|---|---|---|
Neuraptive Therapeutics, Inc.
 Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Directeur des opérations | 24/10/2022 |
Anciens postes connus de Evan Tzanis
| Sociétés | Poste | Fin |
|---|---|---|
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Corporate Officer/Principal | 01/08/2014 |
| PARATEK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Health Technology |